KARIM AMIGHI,MATTHIAS VAN WOENSEL,NATHALIE WAUTHOZ,RÉMI ROSIERE,STEVEN DE VLEESCHOUWER
申请号：
BR112018010292
公开号：
BR112018010292A2
申请日:
2016.11.23
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention relates generally to the novel formulations of the nano particle containing encapsulating siRNA, are used to participate in the gene silencing of the galactose agglutinin 1 of tumour progression using RNAi technology.More particularly it relates to treat nervous centralis cancer using RNAi molecule, more specifically glioblastoma multiforme (GBM) is treated.
